Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockman6767on Jul 20, 2020 4:32pm
164 Views
Post# 31292524

RE:RE:Wasn't this Prometic's business?

RE:RE:Wasn't this Prometic's business?
PLITheOne wrote: This is the business that the Quebec government gave a grant to develop in Quebec a couple years back. Funny thing is that PLI stated that they have nothing to worry about as their separation is far more pure and with greater yields than Green Cross with their fractionation. Then TV stole Prometic, I'm thinking to destroy it as other companies were concerned about their disruptive technology on many platforms. They needed someone to come in and destroy Prometic and the potential it had to damage other drug companies. They wrote off IVIG only because it would have generated revenue. IVIG is the key protein in plasma to wipe out Covid, look it up. These guys are up to no good if you haven't figured it out. Galbraith should be behind bars, not casually stealing tens of millions a year. 


I did some checking, and, it turns  out the PliTheOne was right on the mark about IVIG and Covid. There are numerous papers and articles about IVIG being investigated as a treatment  for adults with severe Covid-19. This could certainly be relevant to the value of IVIG and raise questions of why TV has sidelined this protein that was ready to go even before Covid. The following are just a few of the papers and articles on the matter.
Clin Immunol. 2020 Jul; 216: 108459.
Published online 2020 May 11. doi: 10.1016/j.clim.2020.108459
PMCID: PMC7211658
PMID: 32418917
Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!
Alan A. Nguyen,1 Saddiq B. Habiballah,1 Craig D. PlattRaif S. GehaJanet S. Chou,2 and Douglas R. McDonald,2https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211658/J Infect. 2020 Apr 10
doi: 10.1016/j.jinf.2020.03.044 [Epub ahead of print]
PMCID: PMC7151471
PMID: 32283154
Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19
Yun Xie,a,1 Song Cao,b,1 Hui Dong,b,1 Qingyun Li,c Erzhen Chen,d Wenkai Zhang,b Luyu Yang,b, Shouzhi Fu,b, and Ruilan Wanga,
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151471/Some Studies Suggest IV Immunoglobulin Could Help Treat COVID-19
Published: May 04, 2020 By Mark Terry
https://www.biospace.com/article/intravenous-immunoglobulin-being-tested-to-treat-covid-19/FDA OKs Octapharma’s IVIG to Begin Phase 3 Trial for Severe COVID-19
May 22, 2020
Jennifer Barrett
https://www.drugtopics.com/view/fda-oks-octapharmas-ivig-begin-phase-3-trial-severe-covid-19High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019 
Wei
Cao, Xiaosheng Liu, Tao Bai, Hongwei Fan, Ke Hong, Hui Song, Yang Han, Ling Lin, Lianguo Ruan, Taisheng Li 
Author
Notes
Open Forum Infectious Diseases, Volume 7, Issue 3, March 2020,
https://academic.oup.com/ofid/article/7/3/ofaa102/5810740High-Dose IVIg Reversed Worsening COVID-19 in Case Reports
MAR 25, 2020 | KENNETH BENDER, PHARMD, MA
https://www.contagionlive.com/news/highdose-ivig-reversed-worsening-covid19-in-case-reports
<< Previous
Bullboard Posts
Next >>